# ONI Framework: Pediatric and Incapacity Considerations

> Ethical guidelines for neural device use in minors and individuals with limited decision-making capacity.

**Last Updated:** 2026-01-24
**Version:** 1.0
**Status:** Active Development

---

## Table of Contents

- [Overview](#overview)
- [Scope of Application](#scope-of-application)
- [Key Ethical Concerns](#key-ethical-concerns)
  - [Clinician-Identified Concerns](#clinician-identified-concerns-lázaro-muñoz-et-al-2023)
  - [Adolescent-Specific Concerns](#adolescent-specific-concerns)
- [Consent and Assent Framework](#consent-and-assent-framework)
  - [Tri-Level Authorization Model](#tri-level-authorization-model)
  - [Age-Appropriate Assent](#age-appropriate-assent)
  - [Dissent Handling](#dissent-handling)
- [Developmental Considerations](#developmental-considerations)
  - [The Developing Brain](#the-developing-brain)
  - [Transition to Adult Care](#transition-to-adult-care)
- [Incapacity Considerations](#incapacity-considerations)
  - [Variable Capacity](#variable-capacity)
  - [Advance Directives for Neural Devices](#advance-directives-for-neural-devices)
- [Special Protections](#special-protections)
- [Integration with ONI Framework](#integration-with-oni-framework)
- [References](#references)

---

## Overview

This document addresses the unique ethical challenges of deploying neural devices in pediatric populations and individuals who cannot provide full autonomous consent. It is informed by extensive research from [Gabriel Lázaro-Muñoz and colleagues](https://pmc.ncbi.nlm.nih.gov/articles/PMC10586720/) whose NIH-funded studies (R01MH121371) have examined pediatric deep brain stimulation ethics.

**Foundational Principle:**

> "From both an ethical and a clinical standpoint, it is very important not to treat minors as small adults." — Gabriel Lázaro-Muñoz, PhD, JD

---

## Scope of Application

This document applies to ONI-compliant devices deployed in:

| Population | Age/Capacity | Key Considerations |
|------------|--------------|-------------------|
| **Pediatric** | Under 18 years | Developing brain, evolving autonomy, surrogate consent |
| **Adolescent** | 12-17 years | Emerging autonomy, assent capacity, identity formation |
| **Cognitive impairment** | Any age | Variable capacity, supported decision-making |
| **Temporary incapacity** | Any age | Emergency protocols, advance directives |

---

## Key Ethical Concerns

### Clinician-Identified Concerns (Lázaro-Muñoz et al., 2023)

Research with 29 clinicians caring for pediatric patients identified four pressing concerns:

| Concern | Frequency | Description |
|---------|-----------|-------------|
| **Uncertainty about risks/benefits** | 72% | Challenge to informed decision-making |
| **Decision-making roles** | 52% | How to integrate stakeholder perspectives |
| **Information scarcity** | 52% | Limited data affects consent quality |
| **Regulatory status/access** | 24% | Lack of FDA-approved indications |

### Adolescent-Specific Concerns

| Issue | Clinician Concern Rate | ONI Implication |
|-------|----------------------|-----------------|
| **Adolescent assent capacity** | 80% | Age-appropriate assent protocols required |
| **Identity formation effects** | High | Device effects on developing sense of self |
| **Long-term unknown effects** | High | Developing brain plasticity considerations |

---

## Consent and Assent Framework

### Tri-Level Authorization Model

```
┌─────────────────────────────────────────────────────────────┐
│               PEDIATRIC AUTHORIZATION MODEL                  │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  Level 1: PARENTAL/GUARDIAN CONSENT                         │
│  ├── Full informed consent from legal guardian              │
│  ├── Understanding of child-specific risks                  │
│  └── Long-term commitment acknowledgment                    │
│                                                             │
│  Level 2: MINOR'S ASSENT (age-appropriate)                  │
│  ├── Developmentally appropriate explanation                │
│  ├── Opportunity to ask questions                           │
│  ├── Voluntary agreement (or documented dissent)            │
│  └── Understanding that disagreement is respected           │
│                                                             │
│  Level 3: CLINICIAN CERTIFICATION                           │
│  ├── Medical necessity determination                        │
│  ├── Developmental impact assessment                        │
│  └── Alternative treatment consideration                    │
│                                                             │
└─────────────────────────────────────────────────────────────┘
```

### Age-Appropriate Assent

| Age Range | Assent Approach | Documentation |
|-----------|-----------------|---------------|
| **0-6 years** | No formal assent; minimize distress | Parental consent only |
| **7-11 years** | Simple explanation; verbal assent | Documented discussion |
| **12-14 years** | Detailed explanation; written assent | Formal assent form |
| **15-17 years** | Near-adult discussion; strong assent weight | Assent + transition plan |

### Dissent Handling

> "Although pediatric patients cannot legally make their own decisions, many adolescents can and should be engaged in the decision making process in age-appropriate ways." — Dr. Jennifer Blumenthal-Barby

If a minor expresses dissent:

1. **Document the dissent** — Record the child's concerns
2. **Explore reasons** — Understand the basis for refusal
3. **Weigh seriously** — Dissent should influence decision
4. **Override only with justification** — Clear documentation if proceeding
5. **Re-evaluate periodically** — Assent status should be reassessed

---

## Developmental Considerations

### The Developing Brain

| Factor | Consideration | ONI Implication |
|--------|---------------|-----------------|
| **Brain plasticity** | Higher adaptability, unknown long-term effects | Conservative thresholds |
| **Developmental milestones** | Device may affect normal development | Milestone monitoring |
| **Identity formation** | Adolescent identity still developing | Enhanced L14 protections |
| **Changing capacity** | Autonomy increases over time | Transition planning |

### Transition to Adult Care

```
┌─────────────────────────────────────────────────────────────┐
│               PEDIATRIC-TO-ADULT TRANSITION                  │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  Age 14-15: Transition planning begins                      │
│  ├── Educate minor about device and condition               │
│  ├── Introduce independent decision-making concept          │
│  └── Begin documenting minor's preferences                  │
│                                                             │
│  Age 16-17: Increasing autonomy                             │
│  ├── Minor takes lead in clinical discussions               │
│  ├── Practice independent consent decisions                 │
│  └── Identify adult care providers                          │
│                                                             │
│  Age 18+: Full autonomy transfer                            │
│  ├── Independent consent (new consent process)              │
│  ├── Access to all records and history                      │
│  └── Full control over device parameters                    │
│                                                             │
└─────────────────────────────────────────────────────────────┘
```

---

## Incapacity Considerations

### Variable Capacity

| Capacity Level | Decision Authority | Safeguards |
|----------------|-------------------|------------|
| **Full capacity** | Individual consent | Standard framework |
| **Fluctuating** | Supported decision-making | Lucid interval documentation |
| **Partial** | Co-decision with support | Maximize participation |
| **No capacity** | Surrogate decision-maker | Best interest standard |

### Advance Directives for Neural Devices

```markdown
## Neural Device Advance Directive

**Prepared by:** [Name]
**Date:** [Date]

### If I lose decision-making capacity:

**Designated decision-maker:** [Name, relationship]

### My preferences:

**Continue device operation:** [ ] Yes [ ] No [ ] Defer
**Device modifications:** [ ] Permitted [ ] Not permitted
**Device removal if no benefit:** [ ] Yes [ ] No [ ] Defer

### Values to guide decisions:

[Free text describing what matters most]
```

---

## Special Protections

### Identity Protection in Developing Brains

| Protection | Implementation | Rationale |
|------------|----------------|-----------|
| **Psychological continuity monitoring** | Regular assessments | L14 protection for developing self |
| **Personality change detection** | Baseline + periodic evaluation | 30% researcher concern rate |
| **Reversibility preference** | Favor reversible interventions | Preserve developmental options |

### Enhanced Oversight

1. **Ethics committee review** — Required for initial deployment
2. **Periodic re-review** — Annual or with significant changes
3. **Adverse event escalation** — Faster reporting timelines
4. **Third-party monitoring** — Independent developmental assessment

---

## Integration with ONI Framework

### Proposed Consent State Extension

```python
class PediatricConsentState(Enum):
    NO_CONSENT = 0
    GUARDIAN_ONLY = 1          # Young child
    GUARDIAN_PLUS_ASSENT = 2   # Minor with assent
    TRANSITIONAL = 3           # 16-17, increasing autonomy
    ADULT_FULL = 4             # 18+, full consent
    SURROGATE = 5              # Adult with incapacity
    SUPPORTED = 6              # Supported decision-making
```

---

## References

Lázaro-Muñoz, G., et al. (2023). Deep Brain Stimulation for Pediatric Dystonia: Clinicians' Perspectives on the Most Pressing Ethical Challenges. *Stereotactic and Functional Neurosurgery*. https://doi.org/10.1159/000530694

Muñoz, K. A., Blumenthal-Barby, J., Storch, E. A., Torgerson, L., & Lázaro-Muñoz, G. (2020). Pediatric Deep Brain Stimulation for Dystonia: Current State and Ethical Considerations. *Cambridge Quarterly of Healthcare Ethics*, 29(4), 557-573.

Muñoz, K. A., & Lázaro-Muñoz, G. (2021). Pressing ethical issues in considering pediatric deep brain stimulation for obsessive-compulsive disorder. *Brain Stimulation*, 14(6), 1568-1576.

---

← Back to [INFORMED_CONSENT_FRAMEWORK.md](INFORMED_CONSENT_FRAMEWORK.md) | [INDEX.md](../INDEX.md)
